Travere Therapeutics (TVTX) Beats Q4 Earnings Estimates by $0.13
Travere Therapeutics (NASDAQ:TVTX) reported quarterly earnings results on February 19, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share…
Read more
